Novel compounds as receptor modulators with therapeutic utility

Details for Australian Patent Application No. 2010324988 (hide)

Owner Allergan, Inc.

Inventors Heidelbaugh, Todd M.; Nguyen, Phong X.

Agent Davies Collison Cave

Pub. Number AU-A-2010324988

PCT Pub. Number WO2011/066184

Priority 61/264,038 24.11.09 US

Filing date 19 November 2010

Wipo publication date 3 June 2011

International Classifications

C07D 263/32 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 277/24 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/42 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/16 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/066184 Priority application(s): WO2011/066184

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324992-System and method for measurement incorporating a crystal oscillator

2010324987-Novel spiropiperidine compounds